Securely Sealed in Freezing Cold
Innovative active ingredients such as mRNA, biologics, or cell and gene therapies not only bring progress—they also place the highest demands on their packaging. The situation becomes particularly critical when drugs are stored and transported at high sub-zero temperatures. In
Needle-Trap: Less Material, More Efficiency
Safety for the user, cost efficiency for the manufacturer, and a clear gain for the environment: With Needle-Trap, Schreiner MediPharm offers a unique system for protection against needlestick injuries combining economy and sustainability in a single product—while setting standards.
Together for More Sustainability
United by an ambitious goal: The members of the Alliance to Zero are committed to sustainably reducing CO₂ emissions along the pharmaceutical supply chain—with a view toward compliance with the Paris Climate Agreement. Halfway into the year, the network got
Focus on Drug Protection
Biologics, mRNA therapies, antibody drug conjugates (ADCs) as anticancer drugs, and other novel pharmaceuticals are highly effective—but equally sensitive. Reliably protecting them requires more than just suitable primary packaging. At Schreiner MediPharm, Corinna Endres, Product Manager Drug Protection, oversees tailored
Optimal Protection for Syringes: Digitalization and Efficiency Increase
Digital solutions are key for enhanced inventory management and patient safety in hospital environments. At the same time, product integrity has to be ensured until the point of use. Schreiner MediPharm’s Cap-Lock Label with RFID functionality enables digital tracking of
Triple Light Protection for Syringes
Light-sensitive substances such as biologics or biosimilars react sensitively to UV and light rays—which may impair their efficacy and shelf life. Schreiner MediPharm meets this challenge with innovative light protection labels that not only protect the sensitive substances but also
Smart Packaging, Measurable Results
Schreiner MediPharm extends its offering of smart packaging solutions by the new Smart Syringe Box. Thanks to integrated electronics, a wide variety of syringe packaging can now be digitized. The innovative solution enables automatic tracking of drug administration in clinical
New Packaging for Syringes: Secure, Sustainable, Blister-Free
Schreiner MediPharm together with SCHOTT Pharma and Körber Pharma has developed an innovative packaging concept for prefilled syringes requiring no blister packaging. The new solution offers numerous benefits in terms of sustainability, security, and cost efficiency and met with strong
The Future of Clinical Trials
Digital Display Labels are a groundbreaking new approach for clinical trials. They enable flexible, digital marking of investigational drugs and have the potential to replace conventional labels in the future, eliminating the need for time-consuming re-labeling. This not only optimizes
NFC Labels: Interactive and Counterfeit-Protection
Counterfeit medicines pose a great risk to patients—and entail a loss of image and trust for the pharmaceutical manufacturers concerned. High-priced drugs and those in great demand are particularly attractive for counterfeiters. With its NFC labels, Schreiner MediPharm offers a